Key facts
- An outbreak of Shigella infected 169 non-human primates at the Wisconsin National Primate Research Center.
- The prolonged outbreak provided researchers with extensive immunological data.
- Scientists identified specific bacterial molecules (O-antigen, T3SS proteins) that are effective targets for antibodies.
- The precise locations where potent antibodies bind to these targets were pinpointed.
- The findings are expected to aid in the rational design of Shigella vaccine candidates.
An extensive Shigella outbreak among non-human primates at the Wisconsin National Primate Research Center, which affected 169 animals over more than two years, has yielded valuable data for vaccine development. Researchers analyzed immunological responses from the infected primates, identifying specific molecular targets on the Shigella bacteria that are crucial for mounting effective immune defenses. The study, published in Science Translational Medicine, focused on understanding how the immune system attacks components like the O-antigen and type 3 secretion system (T3SS) proteins of the bacteria.
Scientists were able to pinpoint precise locations on these bacterial structures where potent antibodies attach, a critical insight for designing vaccines. They observed that some antibodies could effectively trigger the disintegration of bacterial cells, while others targeted specific sites on T3SS proteins like IpaB and IpaD, spurring protective responses from immune cells, including T cells. The research also noted that some antibodies prevented harmful blood cell bursting, identifying the exact binding niches for these beneficial antibodies.
Shigella is a significant global health concern, causing over 200 million infections and more than 200,000 deaths annually, particularly among children. The bacteria are also increasingly resistant to antibiotics, underscoring the urgent need for a broad-spectrum vaccine. While previous vaccine development efforts have been hampered by a lack of detailed molecular data, the extensive dataset generated by this natural outbreak offers a promising path forward for designing more sophisticated and effective Shigella vaccines.